99337-98-1

Basic information

• Product Name: 2-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-ISOINDOLE-1,3(2H)-DIONE
• Synonyms: 2-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-ISOINDOLE-1,3(2H)-DIONE;TRANS-2-(4-HYDROXY-CYCLOHEXYL)-ISOINDOLE-1,3-DIONE;2-(trans-4-Hydroxycyclohexyl)isoindole-1,3-dione;trans-2-(4-Hydroxycyclohexyl)-1H-isoindole-1,3(2H)-dione;trans-N-(4-Hydroxycyclohexyl)phthalimide;2-(trans-4-Hydroxycyclohexyl)isoindoline-1,3-dione;2-(trans-4-Hydroxycyclohexyl)-1H-isoindoline-1,3-dione;1H-Isoindole-1,3(2H)-dione, 2-(trans-4-hydroxycyclohexyl)-
• CAS NO: 99337-98-1
• Molecular Formula: C₁₄H₁₅NO₃
• Molecular Weight: 245.2738
• Mol File: 99337-98-1.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 410.056oC at 760 mmHg
• Flash Point: 201.795oC
• Appearance: /
• Density: 1.365
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.643
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 14.99±0.40(Predicted)
• CAS DataBase Reference: 2-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-ISOINDOLE-1,3(2H)-DIONE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-ISOINDOLE-1,3(2H)-DIONE(99337-98-1)
• EPA Substance Registry System: 2-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-ISOINDOLE-1,3(2H)-DIONE(99337-98-1)

Safety Data

• Hazardous Substances Data: 99337-98-1(Hazardous Substances Data)

Usage

Description

2-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-ISOINDOLE-1,3(2H)-DIONE is a chemical compound that serves as an impurity in Pramipexole, a medication used for the treatment of Parkinson's disease and restless legs syndrome.

Uses

Used in Pharmaceutical Industry:
2-(TRANS-4-HYDROXYCYCLOHEXYL)-1H-ISOINDOLE-1,3(2H)-DIONE is used as an impurity in Pramipexole (P700755), a dopamine-D2-receptor agonist, for the early treatment of Parkinson's disease and restless legs syndrome. Its presence as an impurity is significant in the context of drug development and quality control, ensuring the safety and efficacy of the medication.

InChI:InChI=1/C14H15NO3/c16-10-7-5-9(6-8-10)15-13(17)11-3-1-2-4-12(11)14(15)18/h1-4,9-10,16H,5-8H2/t9-,10-

Upstream product

• 22509-74-6 N-ethoxycarbonylphthalimide 
• 27489-62-9 trans-4-hydroxycyclohexylamine 
• 50910-54-8 trans-4-aminocyclohexanol hydrochloride 
• 85-44-9 phthalic anhydride 

Downstream Products

• 104618-32-8 2-(4-oxocyclohexyl)-1H-isoindole-1,3(2H)-dione 
• 478832-23-4 cis-4-nitrobenzoic acid 4-(1,3-dioxo-1,3-dihydroisoindol-2-yl)cyclohexyl ester 
• 948304-18-5 cis-2-[4-(4-bromophenoxy)cyclohexyl]isoindole-1,3-dione 
• 948304-19-6 cis-2-[4-(4-methoxyphenoxy)cyclohexyl]isoindole-1,3-dione 
• 948304-20-9 cis-2-[4-(4-nitrophenoxy)cyclohexyl]isoindole-1,3-dione 
• 885012-39-5 cis-2-[4-(4-fluoro-phenoxy)-cyclohexyl]-isoindole-1,3-dione 
• 948304-22-1 cis-2-[4-(3,5-difluorophenoxy)cyclohexyl]isoindole-1,3-dione 
• 948304-23-2 cis-4-[4-(1,3-dioxo-1,3-dihydroisoindol-2-yl)cyclohexyloxy]benzoic acid ethyl ester 
• 948304-25-4 cis-2-[4-(1,3-dioxo-1,3-dihydroisoindol-2-yl)cyclohexyloxy]benzoic acid ethyl ester 
• 916489-73-1 cis-4-(4-fluoro-phenoxy)-cyclohexylamine 
• 948304-36-7 trans-4-{4-[3-(4-trifluoromethoxyphenyl)ureido]cyclohexyloxy}benzoic acid ethyl ester 
• 948304-37-8 cis-4-{4-[3-(4-trifluoromethoxyphenyl)ureido]cyclohexyloxy}benzoic acid ethyl ester 
• 948304-38-9 cis-4-{4-[3-(4-methoxycarbonylphenyl)ureido]cyclohexyloxy}benzoic acid ethyl ester 
• 948303-89-7 cis-4-nitro-benzoic acid 4-amino-cyclohexyl ester 

Relevant articles and documents

Cobalt-Catalyzed Desymmetric Isomerization of Exocyclic Olefins

Chiral cyclic olefins, 1-methylcyclohexenes, are versatile building blocks for the synthesis of pharmaceuticals and natural products. Despite the prevalence of these structural motifs, the development of efficient synthetic methods remains an unmet challenge. Herein we report a novel desymmetric isomerization of exocyclic olefins using a series of newly designed chiral cobalt catalysts, which enables a straightforward construction of chiral 1-methylcyclohexenes with diversified functionalities. The synthetic utility of this methodology is highlighted by a concise and enantioselective synthesis of a natural product, β-bisabolene. The versatility of the reaction products is further demonstrated by multifarious derivatizations.

POLYCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)

The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g., leukemia, lymphoma, melanoma, multiple myeloma, breast cancer, Ewing' s sarcoma, osteosarcoma, brain cancer, neuroblastoma, lung cancer), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of a kinase, such as a cyclin-dependent kinase (CDK) (e.g., cyclin-dependent kinase 7 (CDK7), cyclin-dependent kinase 12 (CDK12), or cyclin-dependent kinase 13 (CDK13)), and therefore, induce cellular apoptosis and/or inhibit transcription in the subject.

SUBSTITUTED PYRROLOTRIAZINES AS PROTEIN KINASE INHIBITORS

The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) pyrrolotriazines inhibit protein kinase activity thereby making them useful as anticancer agents.